trending Market Intelligence /marketintelligence/en/news-insights/trending/l2qXal4BJ3WT0xKlHAtu4w2 content esgSubNav
In This List

Boston Scientific expands presence in cardiology with $435M acquisition

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Boston Scientific expands presence in cardiology with $435M acquisition

Boston Scientific Corp. is acquiring Swiss medical technology company Symetis SA for $435 million in upfront cash.

Symetis, which has about 300 employees worldwide, is in the business of heart implants. Its portfolio includes the Acurate TA and Acurate neo/TF valve systems for treating patients with aortic valve stenosis, the narrowing of the aortic valve in the heart.

The acquisition is projected to close during the second quarter of 2017, subject to closing conditions.

Boston Scientific also recently acquired some of Neovasc Inc.'s manufacturing assets, in line with the company's investment in structural heart solutions.